Skip to content
healthcare.dev
Get a free key

LYTENAVA

NDC 82491-025, bevacizumab-vikg, injection, from Outlook Therapeutics, Inc..

Product NDC
82491-025
Status
Listed
Labeler
Outlook Therapeutics, Inc.
Dosage form
INJECTION
Route
INTRAVITREAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761320
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82491-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BEVACIZUMAB1.25 mg/1

Pharmacologic classes

Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]; Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
82491-025-10824910025101 VIAL, GLASS in 1 CARTON (82491-025-10) / 1 INJECTION in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7f9a3014-b3d4-4943-a83a-92a77d8f947c

Use it

Look up 82491-025 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82491-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82491-025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.